India to United Arab Emirates: Empagliflozin Export Trade Route

The India to United Arab Emirates Empagliflozin corridor is one of India's established pharmaceutical export routes, with 437 shipments documented worth a combined $545.4K USD. The route is dominated by KWALITY PHARMACEUTICALS LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.

Across 18 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with empagliflozin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 20.4%, placing it at rank #5 among India's top empagliflozin export destinations globally.

On the import side, key buyers of Indian empagliflozin in United Arab Emirates include DAWAA DRUG STORE LLC, CAT INTERNATIONAL TRADING, EMIRATES POST COMPANY. and 13 others. DAWAA DRUG STORE LLC is the single largest importer with 49 shipments valued at $83.4K USD.

India's empagliflozin exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. KWALITY PHARMACEUTICALS LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — KWALITY PHARMACEUTICALS LIMITED, GAIA TRADE PRIVATE LIMITED, GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED — together account for 68% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as empagliflozin tabletbatch no: gt64 , manufacturing : 07/2022, exp: 06/2025 and empagliflozin tablets each film coatedtablet contains empagliflozin 25mg batch no gt410 mfg 01 2023 exp 12 202, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DAWAA DRUG STORE LLC is the largest importer with 49 shipments worth $83.4K USD — representing 15% of all empagliflozin imports from India on this route. A total of 16 buyers are active on this corridor.